Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
29.90
-1.44 (-4.59%)
Last updated: Jun 6, 2025
SHA:688443 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Cash & Equivalents | 1,691 | 2,035 | 2,892 | 49.28 | 14.15 | 42.48 | Upgrade
|
Trading Asset Securities | 711.49 | 412.58 | 27.71 | 237.36 | 427.11 | 13.78 | Upgrade
|
Cash & Short-Term Investments | 2,403 | 2,448 | 2,920 | 286.64 | 441.25 | 56.27 | Upgrade
|
Cash Growth | -12.89% | -16.16% | 918.65% | -35.04% | 684.19% | 163.06% | Upgrade
|
Accounts Receivable | 15 | 12.01 | - | - | - | 0.63 | Upgrade
|
Other Receivables | 3.4 | 1.38 | 0 | - | 1.53 | 3.66 | Upgrade
|
Receivables | 18.41 | 13.38 | 0 | - | 1.53 | 4.29 | Upgrade
|
Inventory | 52.98 | 50.15 | 55.45 | 56.33 | 33.66 | 15.85 | Upgrade
|
Other Current Assets | 103.28 | 110.59 | 56.56 | 56.03 | 52.76 | 30.38 | Upgrade
|
Total Current Assets | 2,577 | 2,622 | 3,032 | 399 | 529.2 | 106.79 | Upgrade
|
Property, Plant & Equipment | 431.63 | 441.55 | 487.82 | 487.75 | 327.83 | 267.8 | Upgrade
|
Other Intangible Assets | 42.63 | 43.59 | 43.54 | 45.08 | 45.92 | 48.94 | Upgrade
|
Long-Term Deferred Charges | 23.87 | 25.16 | 27.92 | 25.51 | 23.51 | 24.96 | Upgrade
|
Other Long-Term Assets | 14.85 | 13.26 | 3.46 | 4.77 | 76.36 | 49.68 | Upgrade
|
Total Assets | 3,090 | 3,146 | 3,595 | 962.11 | 1,003 | 498.17 | Upgrade
|
Accounts Payable | 73.84 | 67.06 | 83.04 | 67.84 | 46.61 | 33.31 | Upgrade
|
Accrued Expenses | 37.2 | 63.03 | 37.74 | 29.71 | 24.29 | 14.27 | Upgrade
|
Short-Term Debt | - | - | 0.63 | - | - | - | Upgrade
|
Current Portion of Long-Term Debt | 49.82 | 26.24 | - | 5.3 | 0.9 | 0.9 | Upgrade
|
Current Portion of Leases | - | 12.13 | 10.07 | 7.64 | 6.51 | - | Upgrade
|
Other Current Liabilities | 11.85 | 5.82 | 5.4 | 15.87 | 7.7 | 431.42 | Upgrade
|
Total Current Liabilities | 173.77 | 174.29 | 136.87 | 126.37 | 86.01 | 479.91 | Upgrade
|
Long-Term Debt | 859.57 | 786.13 | 608.48 | 738.59 | 535.55 | 349.66 | Upgrade
|
Long-Term Leases | 10.6 | 12.63 | 21.82 | 30.37 | 28.65 | - | Upgrade
|
Long-Term Unearned Revenue | 45.73 | 46.62 | 43.2 | 37.69 | 35.55 | 34.15 | Upgrade
|
Other Long-Term Liabilities | - | - | - | - | 5.08 | 9.51 | Upgrade
|
Total Liabilities | 1,090 | 1,020 | 810.36 | 933.03 | 690.84 | 873.22 | Upgrade
|
Common Stock | 366.68 | 366.68 | 366.68 | 275 | 275 | 200 | Upgrade
|
Additional Paid-In Capital | 4,192 | 4,192 | 4,038 | 573.29 | 279.82 | 249.98 | Upgrade
|
Retained Earnings | -2,539 | -2,418 | -1,621 | -819.21 | -242.84 | -825.04 | Upgrade
|
Treasury Stock | -19.37 | -14.67 | - | - | - | - | Upgrade
|
Shareholders' Equity | 2,001 | 2,126 | 2,784 | 29.08 | 311.98 | -375.05 | Upgrade
|
Total Liabilities & Equity | 3,090 | 3,146 | 3,595 | 962.11 | 1,003 | 498.17 | Upgrade
|
Total Debt | 919.99 | 837.13 | 640.99 | 781.91 | 571.6 | 350.57 | Upgrade
|
Net Cash (Debt) | 1,483 | 1,611 | 2,279 | -495.27 | -130.35 | -294.3 | Upgrade
|
Net Cash Growth | -29.93% | -29.31% | - | - | - | - | Upgrade
|
Net Cash Per Share | 4.03 | 4.38 | 7.11 | -1.80 | -0.47 | - | Upgrade
|
Filing Date Shares Outstanding | 366.68 | 366.68 | 366.68 | 275 | 275 | - | Upgrade
|
Total Common Shares Outstanding | 366.68 | 366.68 | 366.68 | 275 | 275 | - | Upgrade
|
Working Capital | 2,404 | 2,448 | 2,895 | 272.63 | 443.19 | -373.12 | Upgrade
|
Book Value Per Share | 5.46 | 5.80 | 7.59 | 0.11 | 1.13 | - | Upgrade
|
Tangible Book Value | 1,958 | 2,082 | 2,741 | -15.99 | 266.06 | -423.99 | Upgrade
|
Tangible Book Value Per Share | 5.34 | 5.68 | 7.47 | -0.06 | 0.97 | - | Upgrade
|
Buildings | - | 115.03 | 114.98 | 105.89 | 99.77 | 99.77 | Upgrade
|
Machinery | - | 516.53 | 457.63 | 302.65 | 261.93 | 214.75 | Upgrade
|
Construction In Progress | - | 6.74 | 52.18 | 164.82 | 18.27 | 9.32 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.